메뉴 건너뛰기




Volumn 15, Issue 3, 2010, Pages 293-300

Viral infections in pediatric solid organ transplantation recipients and the impact of molecular diagnostic testing

Author keywords

Antiviral therapy; Molecular diagnostic testing; Viral infection in transplantation

Indexed keywords

ACICLOVIR; AMANTADINE; CIDOFOVIR; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GANCICLOVIR; IMMUNOGLOBULIN; INFLUENZA VACCINE; MOTAVIZUMAB; OSELTAMIVIR; PALIVIZUMAB; PERAMIVIR; RIMANTADINE; RITUXIMAB; TACROLIMUS; VALGANCICLOVIR; ZANAMIVIR;

EID: 77953293357     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283398795     Document Type: Review
Times cited : (3)

References (95)
  • 2
    • 0036524058 scopus 로고    scopus 로고
    • Influenza virus infection in adult solid organ transplant recipients
    • Vilchez RA, McCurry K, Dauber J, et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002; 2:287.
    • (2002) Am J Transplant , vol.2 , pp. 287
    • Vilchez, R.A.1    McCurry, K.2    Dauber, J.3
  • 3
    • 67649216525 scopus 로고    scopus 로고
    • Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak
    • Ginocchio CC, Zhang F, Manji R, et al. Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol 2009; 45:191.
    • (2009) J Clin Virol , vol.45 , pp. 191
    • Ginocchio, C.C.1    Zhang, F.2    Manji, R.3
  • 4
    • 68849091225 scopus 로고    scopus 로고
    • Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients
    • Kuypers J, Campbell AP, Cent A, et al. Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients. Transpl Infect Dis 2009; 11:298.
    • (2009) Transpl Infect Dis , vol.11 , pp. 298
    • Kuypers, J.1    Campbell, A.P.2    Cent, A.3
  • 5
    • 3042556185 scopus 로고    scopus 로고
    • Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza a and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1,2,3, and 4
    • Templeton KE, Scheltinga SA, Beersma MF, et al. Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza a and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4. J Clin Microbiol 2004; 42:1564.
    • (2004) J Clin Microbiol , vol.42 , pp. 1564
    • Templeton, K.E.1    Scheltinga, S.A.2    Beersma, M.F.3
  • 6
    • 33746366176 scopus 로고    scopus 로고
    • Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in children
    • Kuypers J, Wright N, Ferrenberg J, et al. Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in children. J Clin Microbiol 2006; 44:2382.
    • (2006) J Clin Microbiol , vol.44 , pp. 2382
    • Kuypers, J.1    Wright, N.2    Ferrenberg, J.3
  • 7
    • 33749570155 scopus 로고    scopus 로고
    • Comparison of multiplex PCR assays and conventional techniques for the diagnostic of respiratory virus infections in children admitted to hospital with an acute respiratory illness
    • Freymuth F, Vabret A, Cuvillon-Nimal D, et al. Comparison of multiplex PCR assays and conventional techniques for the diagnostic of respiratory virus infections in children admitted to hospital with an acute respiratory illness. J Med Virol 2006; 78:1498.
    • (2006) J Med Virol , vol.78 , pp. 1498
    • Freymuth, F.1    Vabret, A.2    Cuvillon-Nimal, D.3
  • 8
    • 1442300734 scopus 로고    scopus 로고
    • Superiority of reversetranscription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children
    • Weinberg GA, Erdman DD, Edwards KM, et al. Superiority of reversetranscription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children. J Infect Dis 2004; 189:706.
    • (2004) J Infect Dis , vol.189 , pp. 706
    • Weinberg, G.A.1    Erdman, D.D.2    Edwards, K.M.3
  • 9
    • 0028830829 scopus 로고
    • Parainfluenza and influenza virus infections in pediatric organ transplant recipients
    • Apalsch AM, Green M, Ledesma-Medina J, et al. Parainfluenza and influenza virus infections in pediatric organ transplant recipients. Clin Infect Dis 1995; 20:394.
    • (1995) Clin Infect Dis , vol.20 , pp. 394
    • Apalsch, A.M.1    Green, M.2    Ledesma-Medina, J.3
  • 10
    • 0028123017 scopus 로고
    • Influenza B virus infection in pediatric solid organ transplant recipients
    • Mauch TJ, Bratton S, Myers T, et al. Influenza B virus infection in pediatric solid organ transplant recipients. Pediatrics 1994; 94 (2 Pt 1):225.
    • (1994) Pediatrics , vol.94 , Issue.2 PART 1 , pp. 225
    • Mauch, T.J.1    Bratton, S.2    Myers, T.3
  • 11
    • 0028823068 scopus 로고
    • Influenza A pneumonitis following treatment of acute cardiac allograft rejection with murine monoclonal anti-CD3 antibody (OKT3)
    • Embrey RP, Geist LJ. Influenza A pneumonitis following treatment of acute cardiac allograft rejection with murine monoclonal anti-CD3 antibody (OKT3). Chest 1995; 108:1456.
    • (1995) Chest , vol.108 , pp. 1456
    • Embrey, R.P.1    Geist, L.J.2
  • 12
    • 72549088697 scopus 로고    scopus 로고
    • Guidance on novel influenza A/H1N1 in solid organ transplant recipients
    • Kumar D, Morris MI, Kotton CN, et al. Guidance on novel influenza A/H1N1 in solid organ transplant recipients. Am J Transplant 2010; 10:18.
    • (2010) Am J Transplant , vol.10 , pp. 18
    • Kumar, D.1    Morris, M.I.2    Kotton, C.N.3
  • 16
    • 77953284889 scopus 로고    scopus 로고
    • Influenza and parainfluenza respiratory viral infection requiring admission in adult lung transplant recipients
    • Vilchez R, McCurry K, Dauber J, et al. Influenza and parainfluenza respiratory viral infection requiring admission in adult lung transplant recipients. Transplantation 1075; 73:.
    • Transplantation , vol.1075 , pp. 73
    • Vilchez, R.1    McCurry, K.2    Dauber, J.3
  • 18
    • 0018272424 scopus 로고
    • Epidemic renal transplant rejection associated with influenza A victoria
    • Keane WR, Helderman JH, Luby J, et al. Epidemic renal transplant rejection associated with influenza A victoria. Proc Clin Dial Transplant Forum 1978; 8:232.
    • (1978) Proc Clin Dial Transplant Forum , vol.8 , pp. 232
    • Keane, W.R.1    Helderman, J.H.2    Luby, J.3
  • 19
    • 34247633653 scopus 로고    scopus 로고
    • Community respiratory virus infections in immunocompromised patients: Hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection
    • Kim YJ, Boeckh M, Englund JA. Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection. Semin Respir Crit Care Med 2007; 28:222.
    • (2007) Semin Respir Crit Care Med , vol.28 , pp. 222
    • Kim, Y.J.1    Boeckh, M.2    Englund, J.A.3
  • 21
    • 66149113991 scopus 로고    scopus 로고
    • Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice
    • Smee DF, Hurst BL, Wong MH, et al. Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice. Antimicrob Agents Chemother 2009; 53:2120.
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 2120
    • Smee, D.F.1    Hurst, B.L.2    Wong, M.H.3
  • 22
    • 70349331605 scopus 로고    scopus 로고
    • Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro
    • Nguyen JT, Hoopes JD, Smee DF, et al. Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro. Antimicrob Agents Chemother 2009; 53:4115.
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 4115
    • Nguyen, J.T.1    Hoopes, J.D.2    Smee, D.F.3
  • 24
    • 0029558176 scopus 로고
    • Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus
    • Mauch TJ, Crouch NA, Freese DK, et al. Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus. J Pediatr 1995; 127:957.
    • (1995) J Pediatr , vol.127 , pp. 957
    • Mauch, T.J.1    Crouch, N.A.2    Freese, D.K.3
  • 25
    • 39749137475 scopus 로고    scopus 로고
    • A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings
    • Madan RP, Tan M, Fernandez-Sesma A, et al. A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings. Clin Infect Dis 2008; 46:712.
    • (2008) Clin Infect Dis , vol.46 , pp. 712
    • Madan, R.P.1    Tan, M.2    Fernandez-Sesma, A.3
  • 26
    • 16644381669 scopus 로고    scopus 로고
    • Guidelines for vaccination of solid organ transplant candidates and recipients
    • Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2004; 4 Suppl 10: 160.
    • (2004) Am J Transplant , Issue.4 SUPPL. 10 , pp. 160
  • 28
    • 7244250306 scopus 로고    scopus 로고
    • Influenza vaccination in orthotopic liver transplant recipients: Absence of post administration ALT elevation
    • Lawal A, Basler C, Branch A, et al. Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation. Am J Transplant 2004; 4:1805.
    • (2004) Am J Transplant , vol.4 , pp. 1805
    • Lawal, A.1    Basler, C.2    Branch, A.3
  • 29
    • 77953287470 scopus 로고    scopus 로고
    • Clinical impact of communityacquired respiratory viruses on bronchiolitis obliterans after lung transplant
    • Kumar D, Erdman D, Keshavjee S, et al. Clinical impact of communityacquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 2031; 5:.
    • Am J Transplant , vol.2031 , pp. 5
    • Kumar, D.1    Erdman, D.2    Keshavjee, S.3
  • 30
    • 33749561630 scopus 로고    scopus 로고
    • Significant morbidity associated with RSV infection in immunosuppressed children following liver transplantation: Case report and discussion regarding need of routine prophylaxis
    • Blanchard SS, Gerrek M, Siegel C, Czinn SJ. Significant morbidity associated with RSV infection in immunosuppressed children following liver transplantation: case report and discussion regarding need of routine prophylaxis. Pediatr Transplant 2006; 10:826.
    • (2006) Pediatr Transplant , vol.10 , pp. 826
    • Blanchard, S.S.1    Gerrek, M.2    Siegel, C.3    Czinn, S.J.4
  • 31
    • 0026569757 scopus 로고
    • Respiratory syncytial virus infections in pediatric liver transplant recipients
    • Pohl C, Green M, Wald ER, Ledesma-Medina J. Respiratory syncytial virus infections in pediatric liver transplant recipients. J Infect Dis 1992; 165:166.
    • (1992) J Infect Dis , vol.165 , pp. 166
    • Pohl, C.1    Green, M.2    Wald, E.R.3    Ledesma-Medina, J.4
  • 32
    • 0029869946 scopus 로고    scopus 로고
    • Respiratory syncytial virus infections in pediatric renal transplant recipients
    • Miller RB, Chavers BM. Respiratory syncytial virus infections in pediatric renal transplant recipients. Pediatr Nephrol 1996; 10:213.
    • (1996) Pediatr Nephrol , vol.10 , pp. 213
    • Miller, R.B.1    Chavers, B.M.2
  • 33
    • 34047143155 scopus 로고    scopus 로고
    • Development of motavizumab, an ultrapotent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract
    • Wu H, Pfarr DS, Johnson S, et al. Development of motavizumab, an ultrapotent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract. J Mol Biol 2007; 368:652.
    • (2007) J Mol Biol , vol.368 , pp. 652
    • Wu, H.1    Pfarr, D.S.2    Johnson, S.3
  • 34
    • 65549124546 scopus 로고    scopus 로고
    • Respiratory syncytial virus prophylaxis: A survey of pediatric solid organ transplant centers
    • Michaels MG, Fonseca-Aten M, Green M, et al. Respiratory syncytial virus prophylaxis: a survey of pediatric solid organ transplant centers. Pediatr Transplant 2009; 13:451.
    • (2009) Pediatr Transplant , vol.13 , pp. 451
    • Michaels, M.G.1    Fonseca-Aten, M.2    Green, M.3
  • 35
    • 85047700111 scopus 로고    scopus 로고
    • Palivizumab is highly effective in suppressing respiratory syncytial virus in an immunosuppressed animal model
    • Ottolini MG, Curtis SR, Mathews A, et al. Palivizumab is highly effective in suppressing respiratory syncytial virus in an immunosuppressed animal model. Bone Marrow Transplant 2002; 29:117.
    • (2002) Bone Marrow Transplant , vol.29 , pp. 117
    • Ottolini, M.G.1    Curtis, S.R.2    Mathews, A.3
  • 36
    • 4043169059 scopus 로고    scopus 로고
    • Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection
    • Saez-Llorens X, Moreno MT, Ramilo O, et al. Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection. Pediatr Infect Dis J 2004; 23:707.
    • (2004) Pediatr Infect Dis J , vol.23 , pp. 707
    • Saez-Llorens, X.1    Moreno, M.T.2    Ramilo, O.3
  • 37
    • 77953288058 scopus 로고    scopus 로고
    • Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients
    • Chavez-Bueno S, Mejias A, Merryman RA, et al. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Pediatr Infect Dis J 1089; 26:.
    • Pediatr Infect Dis J , vol.1089 , pp. 26
    • Chavez-Bueno, S.1    Mejias, A.2    Merryman, R.A.3
  • 38
    • 72949116397 scopus 로고    scopus 로고
    • RNA respiratory viruses in solid organ transplant recipients
    • Ison MG, Michaels MG. RNA respiratory viruses in solid organ transplant recipients. Am J Transplant 2009; 9 (S4):S166.
    • (2009) Am J Transplant , vol.9 , Issue.S4
    • Ison, M.G.1    Michaels, M.G.2
  • 39
    • 0038299439 scopus 로고    scopus 로고
    • Adenovirus infection in pediatric small bowel transplantation recipients
    • Pinchoff RJ, Kaufman SS, Magid MS, et al. Adenovirus infection in pediatric small bowel transplantation recipients. Transplantation 2003; 76:183.
    • (2003) Transplantation , vol.76 , pp. 183
    • Pinchoff, R.J.1    Kaufman, S.S.2    Magid, M.S.3
  • 40
    • 77953293141 scopus 로고    scopus 로고
    • Adenovirus pneumonia in lung transplant recipients
    • Ohori NP, Michaels MG, Jaffe R, et al. Adenovirus pneumonia in lung transplant recipients. Hum Pathol 1073; 26:.
    • Hum Pathol , vol.1073 , pp. 26
    • Ohori, N.P.1    Michaels, M.G.2    Jaffe, R.3
  • 41
    • 0026543499 scopus 로고
    • Adenovirus infection in pediatric liver transplant recipients
    • Michaels MG, Green M, Wald ER, Starzl TE. Adenovirus infection in pediatric liver transplant recipients. J Infect Dis 1992; 165:170.
    • (1992) J Infect Dis , vol.165 , pp. 170
    • Michaels, M.G.1    Green, M.2    Wald, E.R.3    Starzl, T.E.4
  • 42
    • 33748331285 scopus 로고    scopus 로고
    • Adenoviral infections in pediatric transplant recipients: A hospital-based study
    • de Mezerville MH, Tellier R, Richardson S, et al. Adenoviral infections in pediatric transplant recipients: a hospital-based study. Pediatr Infect Dis J 2006; 25:815.
    • (2006) Pediatr Infect Dis J , vol.25 , pp. 815
    • De Mezerville, M.H.1    Tellier, R.2    Richardson, S.3
  • 43
    • 65549144329 scopus 로고    scopus 로고
    • Adenovirus infection and treatment with cidofovir in children after liver transplantation
    • Engelmann G, Heim A, Greil J, et al. Adenovirus infection and treatment with cidofovir in children after liver transplantation. Pediatr Transplant 2009; 13:421.
    • (2009) Pediatr Transplant , vol.13 , pp. 421
    • Engelmann, G.1    Heim, A.2    Greil, J.3
  • 44
    • 12344281761 scopus 로고    scopus 로고
    • Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: Activity against adenovirus replication in vitro
    • Hartline CB, Gustin KM, Wan WB, et al. Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro. J Infect Dis 2005; 191:396.
    • (2005) J Infect Dis , vol.191 , pp. 396
    • Hartline, C.B.1    Gustin, K.M.2    Wan, W.B.3
  • 45
    • 0035806735 scopus 로고    scopus 로고
    • Prediction of severe disseminated adenovirus infection by serum PCR
    • Echavarria M, Forman M, van Tol MJ, et al. Prediction of severe disseminated adenovirus infection by serum PCR. Lancet 2001; 358:384.
    • (2001) Lancet , vol.358 , pp. 384
    • Echavarria, M.1    Forman, M.2    Van Tol, M.J.3
  • 46
    • 33644679022 scopus 로고    scopus 로고
    • A surveillance study of adenovirus infection in adult solid organ transplant recipients
    • Humar A, Kumar D, Mazzulli T, et al. A surveillance study of adenovirus infection in adult solid organ transplant recipients. Am J Transplant 2005; 5:2555.
    • (2005) Am J Transplant , vol.5 , pp. 2555
    • Humar, A.1    Kumar, D.2    Mazzulli, T.3
  • 47
    • 33847634017 scopus 로고    scopus 로고
    • Zoonoses in solid-organ and hematopoietic stem cell transplant recipients
    • Kotton CN. Zoonoses in solid-organ and hematopoietic stem cell transplant recipients. Clin Infect Dis 2007; 44:857.
    • (2007) Clin Infect Dis , vol.44 , pp. 857
    • Kotton, C.N.1
  • 48
    • 51849131989 scopus 로고    scopus 로고
    • Screening of organ and tissue donors for West Nile virus by nucleic acid amplification: A three year experience in Alberta
    • Tilley PA, Fox JD, Lee B, et al. Screening of organ and tissue donors for West Nile virus by nucleic acid amplification: a three year experience in Alberta. Am J Transplant 2008; 8:2119.
    • (2008) Am J Transplant , vol.8 , pp. 2119
    • Tilley, P.A.1    Fox, J.D.2    Lee, B.3
  • 49
    • 33646875293 scopus 로고    scopus 로고
    • Transmission of lymphocytic choriomeningitis virus by organ transplantation
    • Fischer SA, Graham MB, Kuehnert MJ, et al. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 2006; 354:2235.
    • (2006) N Engl J Med , vol.354 , pp. 2235
    • Fischer, S.A.1    Graham, M.B.2    Kuehnert, M.J.3
  • 50
    • 0017743375 scopus 로고
    • Lymphocytic choriomeningitis in laboratory personnel exposed to hamsters inadvertently infected with LCM virus
    • Biggar RJ, Schmidt TJ, Woodall JP. Lymphocytic choriomeningitis in laboratory personnel exposed to hamsters inadvertently infected with LCM virus. J Am Vet Med Assoc 1977; 171:829.
    • (1977) J Am Vet Med Assoc , vol.171 , pp. 829
    • Biggar, R.J.1    Schmidt, T.J.2    Woodall, J.P.3
  • 51
    • 20144376356 scopus 로고    scopus 로고
    • Transmission of rabies virus from an organ donor to four transplant recipients
    • Srinivasan A, Burton EC, Kuehnert MJ, et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005; 352:1103.
    • (2005) N Engl J Med , vol.352 , pp. 1103
    • Srinivasan, A.1    Burton, E.C.2    Kuehnert, M.J.3
  • 52
    • 0038526363 scopus 로고    scopus 로고
    • Transmission of West Nile virus from an organ donor to four transplant recipients
    • Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348:2196.
    • (2003) N Engl J Med , vol.348 , pp. 2196
    • Iwamoto, M.1    Jernigan, D.B.2    Guasch, A.3
  • 53
    • 70749132777 scopus 로고    scopus 로고
    • West Nile virus transmission via organ transplantation and blood transfusion: Louisiana, 2008
    • West Nile virus transmission via organ transplantation and blood transfusion: Louisiana, 2008. MMWR Morb Mortal Wkly Rep 2009; 58:1263.
    • (2009) MMWR Morb Mortal Wkly Rep , vol.58 , pp. 1263
  • 54
    • 77950319535 scopus 로고    scopus 로고
    • Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients
    • Levi ME, Quan D, Ho JT, et al. Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients. Clin Transplant 2009; 23:437-446.
    • (2009) Clin Transplant , vol.23 , pp. 437-446
    • Levi, M.E.1    Quan, D.2    Ho, J.T.3
  • 55
    • 7244234467 scopus 로고    scopus 로고
    • A seroprevalence study of west Nile virus infection in solid organ transplant recipients
    • Kumar D, Drebot MA, Wong SJ, et al. A seroprevalence study of west Nile virus infection in solid organ transplant recipients. Am J Transplant 2004; 4:1883.
    • (2004) Am J Transplant , vol.4 , pp. 1883
    • Kumar, D.1    Drebot, M.A.2    Wong, S.J.3
  • 56
    • 77953285954 scopus 로고    scopus 로고
    • Seroprevalence of West Nile virus infection in solid organ transplant recipients
    • Freifeld AG, Meza J, Schweitzer B, et al. Seroprevalence of West Nile virus infection in solid organ transplant recipients. Transpl Infect Dis 2009.
    • (2009) Transpl Infect Dis
    • Freifeld, A.G.1    Meza, J.2    Schweitzer, B.3
  • 57
    • 33846572432 scopus 로고    scopus 로고
    • Subclinical cytomegalovirus and Epstein-Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation
    • Li L, Chaudhuri A, Weintraub LA, et al. Subclinical cytomegalovirus and Epstein-Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation. Pediatr Transplant 2007; 11:187.
    • (2007) Pediatr Transplant , vol.11 , pp. 187
    • Li, L.1    Chaudhuri, A.2    Weintraub, L.A.3
  • 58
    • 0033611067 scopus 로고    scopus 로고
    • Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients
    • Humar A, Gillingham KJ, Payne WD, et al. Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients. Transplantation 1999; 68:1879.
    • (1999) Transplantation , vol.68 , pp. 1879
    • Humar, A.1    Gillingham, K.J.2    Payne, W.D.3
  • 59
    • 0036723794 scopus 로고    scopus 로고
    • Infections and solid organ transplant rejection: A causeand- effect relationship?
    • Cainelli F, Vento S. Infections and solid organ transplant rejection: a causeand- effect relationship? Lancet Infect Dis 2002; 2:539.
    • (2002) Lancet Infect Dis , vol.2 , pp. 539
    • Cainelli, F.1    Vento, S.2
  • 60
    • 0031956205 scopus 로고    scopus 로고
    • Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients
    • Husni RN, Gordon SM, Longworth DL, et al. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis 1998; 26:753.
    • (1998) Clin Infect Dis , vol.26 , pp. 753
    • Husni, R.N.1    Gordon, S.M.2    Longworth, D.L.3
  • 61
    • 27744472100 scopus 로고    scopus 로고
    • A murine model of dual infection with cytomegalovirus and Pneumocystis carinii: Effects of virus-induced immunomodulation on disease progression
    • Qureshi MH, Garvy BA, Pomeroy C, et al. A murine model of dual infection with cytomegalovirus and Pneumocystis carinii: effects of virus-induced immunomodulation on disease progression. Virus Res 2005; 114 (1-2):35.
    • (2005) Virus Res , vol.114 , Issue.1-2 , pp. 35
    • Qureshi, M.H.1    Garvy, B.A.2    Pomeroy, C.3
  • 62
    • 0030792873 scopus 로고    scopus 로고
    • The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients
    • Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland
    • George MJ, Snydman DR, Werner BG, et al. The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. Am J Med 1997; 103:106.
    • (1997) Am J Med , vol.103 , pp. 106
    • George, M.J.1    Snydman, D.R.2    Werner, B.G.3
  • 63
    • 34547829434 scopus 로고    scopus 로고
    • Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients
    • Asberg A, Humar A, Rollag H, et al. Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2007; 7:2106.
    • (2007) Am J Transplant , vol.7 , pp. 2106
    • Asberg, A.1    Humar, A.2    Rollag, H.3
  • 64
    • 39349116597 scopus 로고    scopus 로고
    • Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients
    • Len O, Gavalda J, Aguado JM, et al. Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients. Clin Infect Dis 2008; 46:20.
    • (2008) Clin Infect Dis , vol.46 , pp. 20
    • Len, O.1    Gavalda, J.2    Aguado, J.M.3
  • 65
    • 65249181619 scopus 로고    scopus 로고
    • Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients
    • Asberg A, Humar A, Jardine AG, et al. Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients. Am J Transplant 2009; 9:1205.
    • (2009) Am J Transplant , vol.9 , pp. 1205
    • Asberg, A.1    Humar, A.2    Jardine, A.G.3
  • 66
    • 2442648883 scopus 로고    scopus 로고
    • Valganciclovir for the prophylaxis of cytomegalovirus disease in pediatric liver transplant recipients
    • Clark BS, Chang IF, Karpen SJ, et al. Valganciclovir for the prophylaxis of cytomegalovirus disease in pediatric liver transplant recipients. Transplantation 2004; 77:1480.
    • (2004) Transplantation , vol.77 , pp. 1480
    • Clark, B.S.1    Chang, I.F.2    Karpen, S.J.3
  • 67
    • 60749110137 scopus 로고    scopus 로고
    • Valganciclovir dosing according to body surface area and renal function in pediatric solid organ transplant recipients
    • Vaudry W, Ettenger R, Jara P, et al. Valganciclovir dosing according to body surface area and renal function in pediatric solid organ transplant recipients. Am J Transplant 2009; 9:636.
    • (2009) Am J Transplant , vol.9 , pp. 636
    • Vaudry, W.1    Ettenger, R.2    Jara, P.3
  • 68
    • 1942469969 scopus 로고    scopus 로고
    • Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients
    • Paya C, Humar A, Dominguez E, et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004; 4:611.
    • (2004) Am J Transplant , vol.4 , pp. 611
    • Paya, C.1    Humar, A.2    Dominguez, E.3
  • 69
    • 40749092437 scopus 로고    scopus 로고
    • Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation
    • Chmiel C, Speich R, Hofer M, et al. Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation. Clin Infect Dis 2008; 46:831.
    • (2008) Clin Infect Dis , vol.46 , pp. 831
    • Chmiel, C.1    Speich, R.2    Hofer, M.3
  • 70
    • 40749108069 scopus 로고    scopus 로고
    • Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation
    • Arthurs SK, Eid AJ, Pedersen RA, et al. Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis 2008; 46:840.
    • (2008) Clin Infect Dis , vol.46 , pp. 840
    • Arthurs, S.K.1    Eid, A.J.2    Pedersen, R.A.3
  • 71
    • 65849405940 scopus 로고    scopus 로고
    • Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: An evidence-based reassessment of safety and efficacy
    • Kalil AC, Freifeld AG, Lyden ER, Stoner JA. Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: an evidence-based reassessment of safety and efficacy. PLoS One 2009; 4:e5512.
    • (2009) PLoS One , vol.4
    • Kalil, A.C.1    Freifeld, A.G.2    Lyden, E.R.3    Stoner, J.A.4
  • 72
    • 34547645045 scopus 로고    scopus 로고
    • Incidence and clinical features of ganciclovirresistant cytomegalovirus disease in heart transplant recipients
    • Li F, Kenyon KW, Kirby KA, et al. Incidence and clinical features of ganciclovirresistant cytomegalovirus disease in heart transplant recipients. Clin Infect Dis 2007; 45:439.
    • (2007) Clin Infect Dis , vol.45 , pp. 439
    • Li, F.1    Kenyon, K.W.2    Kirby, K.A.3
  • 73
    • 39449093095 scopus 로고    scopus 로고
    • Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirus-seronegative liver transplant recipients of cytomegalovirus- seropositive donor allografts
    • Singh N, Wannstedt C, Keyes L, et al. Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirus-seronegative liver transplant recipients of cytomegalovirus-seropositive donor allografts. Liver Transpl 2008; 14:240.
    • (2008) Liver Transpl , vol.14 , pp. 240
    • Singh, N.1    Wannstedt, C.2    Keyes, L.3
  • 74
    • 67649600984 scopus 로고    scopus 로고
    • A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients
    • Madan RP, Campbell AL, Shust GF, et al. A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients. Transplantation 2009; 87:1318.
    • (2009) Transplantation , vol.87 , pp. 1318
    • Madan, R.P.1    Campbell, A.L.2    Shust, G.F.3
  • 75
    • 12344298316 scopus 로고    scopus 로고
    • Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients: Impact on viral load and late-onset cytomegalovirus disease
    • Singh N, Wannstedt C, Keyes L, et al. Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients: impact on viral load and late-onset cytomegalovirus disease. Transplantation 2005; 79:85.
    • (2005) Transplantation , vol.79 , pp. 85
    • Singh, N.1    Wannstedt, C.2    Keyes, L.3
  • 76
    • 33747460001 scopus 로고    scopus 로고
    • Valganciclovir preemptive therapy for the prevention of cytomegalovirus disease in high-risk seropositive solid-organ transplant recipients
    • Diaz-Pedroche C, Lumbreras C, San Juan R, et al. Valganciclovir preemptive therapy for the prevention of cytomegalovirus disease in high-risk seropositive solid-organ transplant recipients. Transplantation 2006; 82: 30.
    • (2006) Transplantation , vol.82 , pp. 30
    • Diaz-Pedroche, C.1    Lumbreras, C.2    San Juan, R.3
  • 77
    • 0030901675 scopus 로고    scopus 로고
    • Cytomegalovirus disease occurring before engraftment in marrow transplant recipients
    • Limaye AP, Bowden RA, Myerson D, Boeckh M. Cytomegalovirus disease occurring before engraftment in marrow transplant recipients. Clin Infect Dis 1997; 24:830.
    • (1997) Clin Infect Dis , vol.24 , pp. 830
    • Limaye, A.P.1    Bowden, R.A.2    Myerson, D.3    Boeckh, M.4
  • 78
    • 30844432417 scopus 로고    scopus 로고
    • Lymphoproliferative disorders after paediatric heart transplantation: A multiinstitutional study
    • Webber SA, Naftel DC, Fricker FJ, et al. Lymphoproliferative disorders after paediatric heart transplantation: a multiinstitutional study. Lancet 2006; 367:233.
    • (2006) Lancet , vol.367 , pp. 233
    • Webber, S.A.1    Naftel, D.C.2    Fricker, F.J.3
  • 79
    • 38149027702 scopus 로고    scopus 로고
    • Chronic high Epstein-Barr viral load state and risk for late-onset posttransplant lymphoproliferative disease/lymphoma in children
    • Bingler MA, Feingold B, Miller SA, et al. Chronic high Epstein-Barr viral load state and risk for late-onset posttransplant lymphoproliferative disease/lymphoma in children. Am J Transplant 2008; 8:442.
    • (2008) Am J Transplant , vol.8 , pp. 442
    • Bingler, M.A.1    Feingold, B.2    Miller, S.A.3
  • 80
    • 0035008468 scopus 로고    scopus 로고
    • The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and posttransplant lymphoproliferative disease following solid organ transplantation
    • Green M, Reyes J, Webber S, Rowe D. The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and posttransplant lymphoproliferative disease following solid organ transplantation. Transpl Infect Dis 2001; 3:97.
    • (2001) Transpl Infect Dis , vol.3 , pp. 97
    • Green, M.1    Reyes, J.2    Webber, S.3    Rowe, D.4
  • 81
    • 33745785855 scopus 로고
    • CMV-IVIG for prevention of Epstein Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients
    • Green M, Michaels MG, Katz BZ, et al. CMV-IVIG for prevention of Epstein Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients. Am J Transplant 1906; 6:.
    • (1906) Am J Transplant , pp. 6
    • Green, M.1    Michaels, M.G.2    Katz, B.Z.3
  • 82
    • 0035187510 scopus 로고    scopus 로고
    • The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: A preliminary experience
    • Kogan-Liberman D, Burroughs M, Emre S, et al. The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience. J Pediatr Gastroenterol Nutr 2001; 33:445.
    • (2001) J Pediatr Gastroenterol Nutr , vol.33 , pp. 445
    • Kogan-Liberman, D.1    Burroughs, M.2    Emre, S.3
  • 83
    • 27844591787 scopus 로고    scopus 로고
    • Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients
    • Lee TC, Savoldo B, Rooney CM, et al. Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients. Am J Transplant 2005; 5:2222.
    • (2005) Am J Transplant , vol.5 , pp. 2222
    • Lee, T.C.1    Savoldo, B.2    Rooney, C.M.3
  • 84
    • 49049109688 scopus 로고    scopus 로고
    • Effect of Epstein-Barr virus sequence variation on performance of the Roche real-time LightCycler PCR assay
    • Feng T, Ye F, Wu J, et al. Effect of Epstein-Barr virus sequence variation on performance of the Roche real-time LightCycler PCR assay. J Clin Microbiol 2008; 46:2463.
    • (2008) J Clin Microbiol , vol.46 , pp. 2463
    • Feng, T.1    Ye, F.2    Wu, J.3
  • 85
    • 42149185667 scopus 로고    scopus 로고
    • EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: Results of a two-arm prospective trial
    • Tsai DE, Douglas L, Andreadis C, et al. EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: results of a two-arm prospective trial. Am J Transplant 2008; 8:1016.
    • (2008) Am J Transplant , vol.8 , pp. 1016
    • Tsai, D.E.1    Douglas, L.2    Andreadis, C.3
  • 87
    • 0031042113 scopus 로고    scopus 로고
    • Posttransplant lymphoproliferative disorders: Summary of Society for Hematopathology Workshop
    • Harris NL, Ferry JA,SwerdlowSH.Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop. Semin Diagn Pathol 1997; 14:8.
    • (1997) Semin Diagn Pathol , vol.14 , pp. 8
    • Harris, N.L.1    Ferry, J.A.2    Swerdlow, S.H.3
  • 88
    • 33644891006 scopus 로고    scopus 로고
    • Treatment of PTLD with rituximab or chemotherapy
    • Elstrom RL, Andreadis C, Aqui NA, et al. Treatment of PTLD with rituximab or chemotherapy. Am J Transplant 2006; 6:569.
    • (2006) Am J Transplant , vol.6 , pp. 569
    • Elstrom, R.L.1    Andreadis, C.2    Aqui, N.A.3
  • 89
    • 27244449778 scopus 로고    scopus 로고
    • Low-dose chemotherapy for Epstein- Barr virus-positive posttransplantation lymphoproliferative disease in children after solid organ transplantation
    • Gross TG, Bucuvalas JC, Park JR, et al. Low-dose chemotherapy for Epstein- Barr virus-positive posttransplantation lymphoproliferative disease in children after solid organ transplantation. J Clin Oncol 2005; 23:6481.
    • (2005) J Clin Oncol , vol.23 , pp. 6481
    • Gross, T.G.1    Bucuvalas, J.C.2    Park, J.R.3
  • 90
    • 0032170108 scopus 로고    scopus 로고
    • Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients
    • Rooney CM, Smith CA, Ng CY, et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 1998; 92:1549.
    • (1998) Blood , vol.92 , pp. 1549
    • Rooney, C.M.1    Smith, C.A.2    Ng, C.Y.3
  • 91
    • 77953288691 scopus 로고    scopus 로고
    • Generation of autologous Epstein-Barr virusspecific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients
    • Savoldo B, Goss J, Liu Z, et al. Generation of autologous Epstein-Barr virusspecific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients. Transplantation 1078; 72:.
    • Transplantation , vol.1078 , pp. 72
    • Savoldo, B.1    Goss, J.2    Liu, Z.3
  • 92
    • 0036530234 scopus 로고    scopus 로고
    • Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication
    • Comoli P, Labirio M, Basso S, et al. Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication. Blood 2002; 99:2592.
    • (2002) Blood , vol.99 , pp. 2592
    • Comoli, P.1    Labirio, M.2    Basso, S.3
  • 93
    • 74049116602 scopus 로고    scopus 로고
    • Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease
    • Brewin J, Mancao C, Straathof K, et al. Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease. Blood 2009; 114:4792.
    • (2009) Blood , vol.114 , pp. 4792
    • Brewin, J.1    Mancao, C.2    Straathof, K.3
  • 94
    • 73449085640 scopus 로고    scopus 로고
    • Generation of Epstein-Barr virusspecific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)
    • De Angelis B, Dotti G, Quintarelli C, et al. Generation of Epstein-Barr virusspecific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506). Blood 2009; 114:4784.
    • (2009) Blood , vol.114 , pp. 4784
    • De Angelis, B.1    Dotti, G.2    Quintarelli, C.3
  • 95
    • 0035401232 scopus 로고    scopus 로고
    • Management of Epstein-Barr virus-induced posttransplant lymphoproliferative disease in recipients of solid organ transplantation
    • Green M. Management of Epstein-Barr virus-induced posttransplant lymphoproliferative disease in recipients of solid organ transplantation. Am J Transplant 2001; 1:103.
    • (2001) Am J Transplant , vol.1 , pp. 103
    • Green, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.